Clinical Trial Detail

NCT ID NCT02555644
Title A Study of LY2606368 With Chemotherapy and Radiation in Participants With Head and Neck Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

oropharynx cancer

head and neck squamous cell carcinoma

laryngeal squamous cell carcinoma

hypopharynx cancer

Therapies

Prexasertib

Cisplatin

Cetuximab

Age Groups: adult

No variant requirements are available.